Down-Regulated FOXO1 in Refractory/Relapse Childhood B-Cell Acute Lymphoblastic Leukemia

Background: Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, with an overall prevalence of 4/100,000, accounting for 25–30% of all childhood cancers. With advances in childhood ALL treatment, the cure rate for childhood ALL has exceeded 80% in most countries. However, refracto...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Qingqing, Jiang, Chuang, Liu, Haiyan, Hao, Wenge, Wang, Pengfei, Huang, Haiying, Li, Ziping, Qian, Jiabi, Qian, Maoxiang, Zhang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686545/
https://www.ncbi.nlm.nih.gov/pubmed/33262946
http://dx.doi.org/10.3389/fonc.2020.579673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686545/
https://www.ncbi.nlm.nih.gov/pubmed/33262946
http://dx.doi.org/10.3389/fonc.2020.579673

Ejemplares similares